Delivery Order SPE2DB24D2109-SPE2DB25FHWJE
Award Date
2/7/25
Potential Completion Date
2/10/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,641.00 and an ultimate completion date of January 15, 2025. The contract covers the procurement of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used to treat diabetes. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used to treat diabetes. The order has a total ceiling value of $86,355.12 and is a firm fixed-price contract with a completion date of December 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,918.73, is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a $18,165.72 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used for diabetes management. The order has a period of performance through February 16, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,741.35, is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of January 30, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for this...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,813.56, is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a medication used for diabetes management. The contract has an ultimate completion date of November 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,714.47, is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of January 13, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this...
This is a $12,217.10 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used to treat diabetes. The award has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,006.87, is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of December 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a $1,161.04 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a specialty medication used for diabetes management. This order is placed under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a broad range of pharmaceutical...